CENPO
Basic information
Region (hg38): 2:24793136-24822376
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- ADCY3-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CENPO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 14 | 25 | ||||
Total | 1 | 0 | 31 | 12 | 3 |
Variants in CENPO
This is a list of pathogenic ClinVar variants found in the CENPO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-24793160-T-C | not specified | Likely benign (Jul 14, 2024) | ||
2-24793181-GGGTGGTCGCGGTGAGTGTGCAAGGCCGC-G | Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities | Likely pathogenic (Jul 15, 2024) | ||
2-24793188-C-G | not specified | Uncertain significance (Mar 02, 2023) | ||
2-24793189-G-A | PTRHD1-related disorder | Likely benign (Aug 28, 2019) | ||
2-24793221-G-A | Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities | Pathogenic (Mar 13, 2024) | ||
2-24793223-C-T | Parkinsonian disorder • Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities | Pathogenic (Dec 14, 2021) | ||
2-24793237-C-G | PTRHD1-related disorder | Likely benign (Aug 13, 2019) | ||
2-24793245-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
2-24793251-G-A | Uncertain significance (Oct 17, 2023) | |||
2-24793251-G-T | PTRHD1-related disorder | Benign (Jun 14, 2019) | ||
2-24793295-T-C | not specified | Uncertain significance (Jul 09, 2024) | ||
2-24793296-A-G | not specified | Uncertain significance (Feb 21, 2024) | ||
2-24793336-C-G | PTRHD1-related disorder | Uncertain significance (Feb 08, 2024) | ||
2-24793338-T-G | not specified | Uncertain significance (Aug 05, 2024) | ||
2-24793939-T-C | not specified | Uncertain significance (Nov 10, 2024) | ||
2-24799719-T-A | not specified | Uncertain significance (Nov 10, 2024) | ||
2-24799722-C-T | not specified | Uncertain significance (Feb 17, 2023) | ||
2-24799748-C-A | not specified | Likely benign (Aug 26, 2024) | ||
2-24799749-G-A | not specified | Uncertain significance (Dec 04, 2024) | ||
2-24799797-C-T | not specified | Uncertain significance (May 27, 2022) | ||
2-24799798-G-A | not specified | Likely benign (Mar 07, 2023) | ||
2-24799809-G-A | not specified | Likely benign (Mar 16, 2022) | ||
2-24799821-G-A | not specified | Uncertain significance (Nov 01, 2021) | ||
2-24799828-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
2-24799842-A-C | not specified | Likely benign (Oct 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CENPO | protein_coding | protein_coding | ENST00000380834 | 6 | 29241 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.89e-9 | 0.239 | 125594 | 1 | 153 | 125748 | 0.000613 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.404 | 148 | 163 | 0.911 | 0.00000874 | 1925 |
Missense in Polyphen | 31 | 40.723 | 0.76123 | 552 | ||
Synonymous | -0.707 | 73 | 65.7 | 1.11 | 0.00000335 | 604 |
Loss of Function | 0.619 | 15 | 17.8 | 0.842 | 0.00000121 | 179 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00325 | 0.00325 |
Ashkenazi Jewish | 0.00398 | 0.00398 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000297 | 0.000294 |
Other | 0.00147 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex. Modulates the kinetochore-bound levels of NDC80 complex. {ECO:0000269|PubMed:16622420, ECO:0000269|PubMed:16716197, ECO:0000269|PubMed:16932742, ECO:0000269|PubMed:18007590}.;
- Pathway
- Signal Transduction;Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal;Amplification of signal from the kinetochores;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RHO GTPases Activate Formins;Nucleosome assembly;RHO GTPase Effectors;Signaling by Rho GTPases;Chromosome Maintenance;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Resolution of Sister Chromatid Cohesion;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.0640
Intolerance Scores
- loftool
- 0.879
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.61
Haploinsufficiency Scores
- pHI
- 0.0963
- hipred
- N
- hipred_score
- 0.438
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.799
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cenpo
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- CENP-A containing nucleosome assembly
- Cellular component
- condensed nuclear chromosome kinetochore;condensed nuclear chromosome, centromeric region;nucleus;nucleoplasm;cytosol;Mis6-Sim4 complex
- Molecular function
- protein binding